title: Carbamazepine kinetics and adverse effects during and after ethanol exposure in alcoholics and in healthy volunteers.
abstract: The influence of ethanol on the single-dose kinetics of carbamazepine (400 mg syrup) was assessed in 7 alcoholics after a debauche (mean daily consumption 240 g ethanol) and after 9 days of controlled abstinence, and in 8 healthy volunteers after intake of the drug with and without a single dose of ethanol (25 g). Twelve h after the first test dose of carbamazepine the alcoholics were treated with the drug for 4 days (200 mg tablet b.d.). Carbamazepine was then withheld until a single test dose was given on day 9. Serum levels of carbamazepine and its 10,11-epoxide metabolite were measured by liquid chromatography. Carbamazepine absorption appeared to be delayed in alcoholics, both after debauche and withdrawal, but its bioavailability did not seem to be reduced. Carbamazepine levels were higher and those of its metabolite lower in alcoholics after a debauche than after 9 days of controlled abstinence, but neither was changed in healthy volunteers after the ingestion of carbamazepine together with a single dose of ethanol. The difference may have been due to inhibition of carbamazepine metabolism by ethanol at the high levels attained in alcoholics but not in volunteers. However, it could also be an expression of the unmasking of enzyme induction after ethanol withdrawal. None of the alcoholics had any withdrawal seizures. Despite similar carbamazepine levels, side effects occurred in all volunteers but in none of the alcoholics, indicating that long-term ethanol exposure may promote central nervous adaptation to the acute untoward effects of carbamazepine.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Alcohol Diseases, Malmö General Hospital, Sweden.
authors.forename: B
authors.initials: B
authors.lastname: Sternebring
authors.forename: A
authors.initials: A
authors.lastname: Lidén
authors.forename: K
authors.initials: K
authors.lastname: Andersson
authors.forename: A
authors.initials: A
authors.lastname: Melander
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000097:blood*; D002220:Carbamazepine / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics*; D004334:Drug Administration Schedule; D000431:Ethanol / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D002220:Carbamazepine; D000431:Ethanol